Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.24.3
Consolidated Balance Sheets (Parenthetical) - USD ($)
Jun. 30, 2024
Jun. 30, 2023
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 398,809 $ 420,354
Revenues in excess of billings, allowance $ 116,148 $ 1,380,141
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 500,000 500,000
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 14,500,000 14,500,000
Common stock, shares issued 12,359,922 12,284,887
Common stock, shares outstanding 11,420,891 11,345,856
Treasury stock, shares 939,031 939,031